Drug Shows Early Promise Against Alzheimer's
The feed delivers news from Ars Technica about a new and promising treatment for Alzheimer's. The drug Etanercept works by disabling the functioning of a cytokine called TNFa, and reportedly caused immediate improvement — in minutes — in mental functioning in one Alaheimer's patient. Double-blind studies have not yet begun.
Why does it matter if the drug works on two blind people?
Moderator hint: a comment is neither "Flamebait" nor "Troll" if it is true.